Mechanical Induction of PGE2 in Osteocytes Blocks Glucocorticoid-Induced Apoptosis Through Both the β-Catenin and PKA Pathways

Glucocorticoids are known to induce osteocyte apoptosis, whereas mechanical loading has been shown to sustain osteocyte viability. Here we show that mechanical loading in the form of fluid‐flow shear stress blocks dexamethasone‐induced apoptosis of osteocyte‐like cells (MLO‐Y4). Prostaglandin E2 (PGE2), a rapidly induced signaling molecule produced by osteocytes, was shown to be protective against dexamethasone‐induced apoptosis, whereas indomethacin reversed the antiapoptotic effects of shear stress. This protective effect of shear stress was mediated through EP2 and EP4 receptors, leading to activation of the cAMP/protein kinase A signaling pathway. Activation of phosphatidylinositol 3‐kinase, an inhibitor of glycogen synthesis kinase 3, also occurred, leading to the nuclear translocation of β‐catenin, an important signal transducer of the Wnt signaling pathway. Both shear stress and prostaglandin increased the phosphorylation of glycogen synthesis kinase 3 α/β. Lithium chloride, an activator of the Wnt pathway, also was protective against glucocorticoid‐induced apoptosis. Whereas it is known that mechanical loading increases cyclooxygenase‐2 and EP2 receptor expression and prostaglandin production, dexamethasone was shown to inhibit expression of these components of the prostaglandin pathway and to reduce β‐catenin protein expression. β‐catenin siRNA knockdown experiments abrogated the protective effects of PGE2, confirming the central role of β‐catenin in mediating the protection against dexamethasone‐induced cell death. Our data support a central role for PGE2 acting through the cAMP/PKA and β‐catenin signaling pathways in the protection of osteocyte apoptosis by fluid‐flow shear stress. © 2010 American Society for Bone and Mineral Research.

[1]  M. Hull,et al.  Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer? , 2004, Molecular cancer therapeutics.

[2]  R. Weinstein,et al.  New Developments in the Pathogenesis and Treatment of Steroid‐Induced Osteoporosis , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  Melissa L. Knothe Tate,et al.  Whither flows the fluid in bone?" An osteocyte's perspective. , 2003 .

[4]  S. Cowin,et al.  A model for the excitation of osteocytes by mechanical loading-induced bone fluid shear stresses. , 1994, Journal of biomechanics.

[5]  Y. Chong,et al.  Mechanisms involved in prostaglandin E2-mediated neuroprotection against TNF-alpha: possible involvement of multiple signal transduction and beta-catenin/T-cell factor. , 2004, Journal of neuroimmunology.

[6]  Yu-Ting Huang,et al.  Wnt/beta-catenin signaling modulates survival of high glucose-stressed mesangial cells. , 2006, Journal of the American Society of Nephrology : JASN.

[7]  P. Meunier,et al.  Comparison of Trabecular Bone Microarchitecture and Remodeling in Glucocorticoid‐Induced and Postmenopausal Osteoporosis , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  L. Bonewald,et al.  Establishment of an Osteocyte‐like Cell Line, MLO‐Y4 , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  K. Druey,et al.  Prostaglandin E2 Promotes Colon Cancer Cell Growth Through a Gs-Axin-ß-Catenin Signaling Axis , 2005, Science.

[10]  L. Bonewald,et al.  Effects of Mechanical Strain on the Function of Gap Junctions in Osteocytes Are Mediated through the Prostaglandin EP2 Receptor* , 2003, Journal of Biological Chemistry.

[11]  P. Roberson,et al.  Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. , 1999, The Journal of clinical investigation.

[12]  J. Regan,et al.  Phosphorylation of Glycogen Synthase Kinase-3 and Stimulation of T-cell Factor Signaling following Activation of EP2 and EP4 Prostanoid Receptors by Prostaglandin E2 * , 2002, The Journal of Biological Chemistry.

[13]  S. Dey,et al.  Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade. , 2005, Cancer research.

[14]  Sheldon Weinbaum,et al.  In situ measurement of solute transport in the bone lacunar‐canalicular system , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Sheng,et al.  Prostaglandin E2 Stimulates the β-Catenin/T Cell Factor-dependent Transcription in Colon Cancer* , 2005, Journal of Biological Chemistry.

[16]  O. Verborgt,et al.  Loss of Osteocyte Integrity in Association with Microdamage and Bone Remodeling After Fatigue In Vivo , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  P. Shepherd,et al.  GSK-3beta regulation in skeletal muscles by adrenaline and insulin: evidence that PKA and PKB regulate different pools of GSK-3. , 2007, Cellular signalling.

[18]  S. Manolagas Corticosteroids and Fractures: A Close Encounter of the Third Cell Kind , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  Mark L. Johnson,et al.  Osteocytes, mechanosensing and Wnt signaling. , 2008, Bone.

[20]  L. Bonewald Osteocytes as Dynamic Multifunctional Cells , 2007, Annals of the New York Academy of Sciences.

[21]  Zhaofeng Huang,et al.  Stabilized beta-catenin extends thymocyte survival by up-regulating Bcl-xL. , 2005, Journal of immunology.

[22]  C. Leu,et al.  Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2). , 2001, Molecular pharmacology.

[23]  L. Lanyon,et al.  Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone. , 2003, American journal of physiology. Cell physiology.

[24]  R. Evans,et al.  Bone death in hip fracture in the elderly , 1990, Calcified Tissue International.

[25]  G. Rodan,et al.  Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity. , 2006, Prostaglandins, leukotrienes, and essential fatty acids.

[26]  A. Robling,et al.  The Wnt Co-receptor LRP5 Is Essential for Skeletal Mechanotransduction but Not for the Anabolic Bone Response to Parathyroid Hormone Treatment* , 2006, Journal of Biological Chemistry.

[27]  A. Parfitt,et al.  Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs. , 2005, American journal of physiology. Cell physiology.

[28]  L. Bonewald,et al.  Mechanical strain opens connexin 43 hemichannels in osteocytes: a novel mechanism for the release of prostaglandin. , 2005, Molecular biology of the cell.

[29]  E H Burger,et al.  Function of osteocytes in bone--their role in mechanotransduction. , 1995, The Journal of nutrition.

[30]  David Taylor,et al.  The cellular transducer in bone: What is it? , 2006, Technology and health care : official journal of the European Society for Engineering and Medicine.

[31]  Jenneke Klein-Nulend,et al.  Osteocytes subjected to pulsating fluid flow regulate osteoblast proliferation and differentiation. , 2006, Biochemical and biophysical research communications.

[32]  A. Parfitt,et al.  Osteocyte Apoptosis Is Induced by Weightlessness in Mice and Precedes Osteoclast Recruitment and Bone Loss , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  J. Regan EP2 and EP4 prostanoid receptor signaling. , 2003, Life sciences.

[34]  Yu-Ting Huang,et al.  Superoxide destabilization of beta-catenin augments apoptosis of high-glucose-stressed mesangial cells. , 2008, Endocrinology.

[35]  A. Bertolotto,et al.  Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis. , 2004, The Journal of clinical endocrinology and metabolism.

[36]  S. Rivest,et al.  Anti‐inflammatory effects of prostaglandin E2 in the central nervous system in response to brain injury and circulating lipopolysaccharide , 2001, Journal of neurochemistry.

[37]  M. Balooch,et al.  Glucocorticoid‐Treated Mice Have Localized Changes in Trabecular Bone Material Properties and Osteocyte Lacunar Size That Are Not Observed in Placebo‐Treated or Estrogen‐Deficient Mice , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[38]  T. Clemens,et al.  Selected Contribution: Osteocytes upregulate HIF-1alpha in response to acute disuse and oxygen deprivation. , 2001, Journal of applied physiology.

[39]  J. A. Robinson,et al.  High Bone Mass in Mice Expressing a Mutant LRP5 Gene , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  B. Frenkel,et al.  Gene expression profiling of glucocorticoid-inhibited osteoblasts. , 2004, Journal of molecular endocrinology.

[41]  Minqi Li,et al.  Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. , 2007, Cell metabolism.

[42]  Y. Chong,et al.  Mechanisms involved in prostaglandin E2-mediated neuroprotection against TNF-α: possible involvement of multiple signal transduction and β-catenin/T-cell factor , 2004, Journal of Neuroimmunology.

[43]  S. Narumiya,et al.  Prostaglandin E Receptors* , 2007, Journal of Biological Chemistry.

[44]  Ming-tao Li,et al.  Cyclic AMP Promotes Neuronal Survival by Phosphorylation of Glycogen Synthase Kinase 3β , 2000, Molecular and Cellular Biology.

[45]  D. Ganea,et al.  Prostaglandin E2 Promotes the Survival of Bone Marrow-Derived Dendritic Cells1 , 2004, The Journal of Immunology.

[46]  Susan R. Johnson,et al.  Osteoporosis prevention, diagnosis, and therapy. , 2001, JAMA.

[47]  H. Itoh,et al.  Induction of apoptosis in bovine articular chondrocyte by prostaglandin E(2) through cAMP-dependent pathway. , 2000, Osteoarthritis and cartilage.

[48]  T. Gross,et al.  Osteocyte hypoxia: a novel mechanotransduction pathway. , 1999, American journal of physiology. Cell physiology.

[49]  E H Burger,et al.  Pulsating fluid flow increases prostaglandin production by cultured chicken osteocytes--a cytoskeleton-dependent process. , 1996, Biochemical and biophysical research communications.

[50]  Lynda F. Bonewald,et al.  Prostaglandin Promotion of Osteocyte Gap Junction Function through Transcriptional Regulation of Connexin 43 by Glycogen Synthase Kinase 3/β-Catenin Signaling , 2009, Molecular and Cellular Biology.

[51]  R. Weinstein,et al.  Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. , 2000, The Journal of clinical endocrinology and metabolism.

[52]  Kay Dickersin,et al.  Osteoporosis prevention, diagnosis, and therapy. , 2000, NIH consensus statement.

[53]  S. Dey,et al.  Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta. , 2004, Cancer cell.

[54]  D. Dempster Perspectives bone histomorphometry in glucocorticoid‐induced osteoporosis , 1989 .

[55]  J A Frangos,et al.  Review: Bone tissue engineering: The role of interstitial fluid flow , 1994, Biotechnology and bioengineering.

[56]  C. Riccardi,et al.  Decrease of Bcl-xL and augmentation of thymocyte apoptosis in GILZ overexpressing transgenic mice. , 2004, Blood.

[57]  S. Dey,et al.  Prostaglandin E2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor δ , 2004 .

[58]  A. van der Plas,et al.  Sensitivity of osteocytes to biomechanical stress in vitro , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[59]  Jenneke Klein-Nulend,et al.  Shear stress inhibits while disuse promotes osteocyte apoptosis. , 2004, Biochemical and biophysical research communications.

[60]  T. Takano,et al.  Prostaglandin E2 promotes cell survival of glomerular epithelial cells via the EP4 receptor. , 2006, American journal of physiology. Renal physiology.

[61]  Melissa L Knothe Tate,et al.  "Whither flows the fluid in bone?" An osteocyte's perspective. , 2003, Journal of biomechanics.

[62]  D. Dempster Bone histomorphometry in glucocorticoid-induced osteoporosis. , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[63]  B. Noble,et al.  Apoptotic Bodies Convey Activity Capable of Initiating Osteoclastogenesis and Localized Bone Destruction , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.